Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tarella

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Biological Regulators and Homeostatic Agents|December 2, 2020
Tips and tricks for writing a scientific manuscriptA Marmotti, G M Peretti, L Mangiavini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cellsP Corradini, C Voena, C Tarella, et al.
Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.
Haematologica|October 6, 1999
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapyM Boccadoro, C Tarella, A Palumbo, et al.
Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.
British Journal of Haematology|September 1, 2001
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphomaS Cortelazzo, A Rambaldi, A Rossi, et al.
Stem Cells International|May 3, 2012
Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro studyA Marmotti, S Mattia, M Bruzzone, et al.
Leukemia|December 26, 2001
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaM Ladetto, F Zallio, S Vallet, et al.
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Biological Regulators and Homeostatic Agents|December 2, 2020
Tips and tricks for writing a scientific manuscriptA Marmotti, G M Peretti, L Mangiavini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cellsP Corradini, C Voena, C Tarella, et al.
Experimental Hematology|February 13, 2001
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patientsM Ladetto, S Sametti, J W Donovan, et al.
Haematologica|October 6, 1999
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapyM Boccadoro, C Tarella, A Palumbo, et al.
Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.
British Journal of Haematology|September 1, 2001
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphomaS Cortelazzo, A Rambaldi, A Rossi, et al.
Stem Cells International|May 3, 2012
Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro studyA Marmotti, S Mattia, M Bruzzone, et al.
Leukemia|December 26, 2001
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaM Ladetto, F Zallio, S Vallet, et al.
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.
Pageof 9